Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 10/6/2025

Insulin Resistance with Normal A1C and Fasting Glucose

Introduction to Insulin Resistance

  • Insulin resistance with compensatory hyperinsulinemia represents one of the earliest metabolic abnormalities in the progression toward type 2 diabetes, often occurring years before glucose levels become abnormal, as recognized by the American Diabetes Association 1, 2
  • The American Diabetes Association acknowledges that type 2 diabetes is characterized by both relative insulin deficiency and peripheral insulin resistance, which exist on a continuum 1, 2

Metabolic Progression and Detection

  • Initial insulin resistance develops with normal glucose homeostasis maintained through compensatory hyperinsulinemia 1, 2
  • A1C increases last as average glucose levels become chronically elevated, following the sequence of postprandial glucose rises and fasting glucose increases 1, 2

Clinical Detection and Risk Stratification

  • Hypertension (≥140/90 mmHg or on antihypertensive therapy) is a clinical marker for hidden insulin resistance 3
  • HDL cholesterol <35 mg/dL and/or triglycerides >250 mg/dL are lipid profiles associated with insulin resistance 4
  • Physical inactivity is a risk factor for insulin resistance 3
  • Even with A1C between 5.5-6.0%, individuals have substantially increased diabetes risk with 5-year incidence of 9-25% 1, 2
  • Those with A1C 5.7-6.4% have 25-50% 5-year diabetes risk, demonstrating a continuous risk relationship 1, 2

Management and Prevention

  • Intensive lifestyle intervention is indicated for individuals who are overweight/obese with risk factors, even without meeting glucose-based diagnostic criteria for prediabetes 3
  • Behavioral counseling interventions have demonstrated moderate benefits in reducing cardiovascular risk, lowering blood pressure, improving glucose and lipid levels, reducing obesity, and increasing physical activity 3
  • Lifestyle interventions are more effective than metformin for preventing progression to diabetes in at-risk individuals 3
  • Cardiovascular risk factor management should be systematically assessed, as insulin resistance increases risk for atherosclerotic cardiovascular disease independent of glucose levels 4